Skip to main content
Premium Trial:

Request an Annual Quote

Roche and Ionian Technologies Strike Product-Development Pact

NEW YORK (GenomeWeb News) – Roche Diagnostics will collaborate with molecular diagnostics company Ionian Technologies in an effort to identify new applications and customers for Ionian's technology.

Ionian said on Thursday that Roche will seek new opportunities for Ionian's NEAR Assay, a rapid isothermal nucleic acid amplification technology, in return for exclusive manufacturing rights if the new applications are commercialized.

Ionian's technology is aimed at applications in human in vitro diagnostics, food safety, biodefense, agriculture, and veterinary applications.

The San Diego-based company said that its technology enables DNA and RNA detection from bacterial or viral pathogens in less than ten minutes.

The collaboration will allow the company "to focus on its core strengths, including technology and assay development, while leveraging the business development, sales, and manufacturing expertise of Roche," Ionian's CEO Andrew Miller said in a statement.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.